LAMIVUDINE
BNopenfda #6fd4d6b9-65ea-4988-8d6f-dd220ec5052dlang: en
- Manufacturer
- Major Pharmaceuticals
- Ingredients
- LAMIVUDINE
- Routes
- ORAL
Extra source metadata
{
"ndc": [
"0904-6583"
],
"rxcui": [
"199147"
],
"pharm_class_epc": [
"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
]
}Source last updated 2026-05-24T14:39:08.004Z